{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:05:37Z","timestamp":1791389137246,"version":"4.3.3"},"reference-count":116,"publisher":"Xia & He Publishing","issue":"X","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,28]]},"DOI":"10.14218\/jcth.2019.00028","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T20:35:51Z","timestamp":1574973351000},"page":"1-9","source":"Crossref","is-referenced-by-count":63,"title":["Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease"],"prefix":"10.14218","volume":"7","author":[{"given":"Daud H.","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umair","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Miguel","family":"Vazquez-Montesino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany B.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"key":"key20191128203548_b1","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/j.gastro.2016.03.005","article-title":"Contribution of alcoholic and nonalcoholic fatty liver disease to the burden of liver-related morbidity and mortality","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"key":"key20191128203548_b2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20191128203548_b3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20191128203548_b4","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1210\/jc.2008-1399","article-title":"Obesity-associated liver disease","volume":"93","author":"Marchesini","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key20191128203548_b5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.beem.2016.06.006","article-title":"Non-alcoholic fatty liver disease and risk of type 2 diabetes","volume":"30","author":"Lallukka","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key20191128203548_b6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key20191128203548_b7","first-page":"9072","article-title":"Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?","volume":"20","author":"Firneisz","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"key20191128203548_b8","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jhep.2008.01.009","article-title":"Non-alcoholic fatty liver disease: the mist gradually clears","volume":"48","author":"de Alwis","year":"2008","journal-title":"J Hepatol"},{"key":"key20191128203548_b9","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","article-title":"Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"key20191128203548_b10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"J Clin Invest"},{"key":"key20191128203548_b11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"key20191128203548_b12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","article-title":"Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha","volume":"7","author":"Alessi","year":"1997","journal-title":"Curr Biol"},{"key":"key20191128203548_b13","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1126\/science.279.5351.710","article-title":"Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B","volume":"279","author":"Stephens","year":"1998","journal-title":"Science"},{"key":"key20191128203548_b14","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1172\/JCI579","article-title":"Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans","volume":"101","author":"Petersen","year":"1998","journal-title":"J Clin Invest"},{"key":"key20191128203548_b15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI200112876","article-title":"The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression","volume":"108","author":"Nakae","year":"2001","journal-title":"J Clin Invest"},{"key":"key20191128203548_b16","first-page":"E154","article-title":"A critical evaluation of mass isotopomer distribution analysis of gluconeogenesis in vivo","volume":"277","author":"Previs","year":"1999","journal-title":"Am J Physiol"},{"key":"key20191128203548_b17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.3579","article-title":"Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis","volume":"20","author":"Perry","year":"2014","journal-title":"Nat Med"},{"key":"key20191128203548_b18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2015.01.012","article-title":"Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes","volume":"160","author":"Perry","year":"2015","journal-title":"Cell"},{"key":"key20191128203548_b19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metab"},{"key":"key20191128203548_b20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cmet.2013.06.001","article-title":"A noncanonical, GSK3-independent pathway controls postprandial hepatic glycogen deposition","volume":"18","author":"Wan","year":"2013","journal-title":"Cell Metab"},{"key":"key20191128203548_b21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"key20191128203548_b22","doi-asserted-by":"crossref","first-page":"e3887","DOI":"10.1097\/MD.0000000000003887","article-title":"Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern","volume":"95","author":"Wehmeyer","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key20191128203548_b23","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"key20191128203548_b24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2337\/diabetes.54.3.603","article-title":"Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes","volume":"54","author":"Petersen","year":"2005","journal-title":"Diabetes"},{"key":"key20191128203548_b25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00125-017-4503-0","article-title":"Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort","volume":"61","author":"Taylor","year":"2018","journal-title":"Diabetologia"},{"key":"key20191128203548_b26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cmet.2017.10.004","article-title":"Mechanisms by which a very-low-calorie diet reverses hyperglycemia in a rat model of type 2 diabetes","volume":"27","author":"Perry","year":"2018","journal-title":"Cell Metab"},{"key":"key20191128203548_b27","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1073\/pnas.1423952112","article-title":"Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids","volume":"112","author":"Vatner","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20191128203548_b28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1210\/jc.2010-2007","article-title":"A dual sugar challenge test for lipogenic sensitivity to dietary fructose","volume":"96","author":"Hudgins","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key20191128203548_b29","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/oby.20377","article-title":"Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans","volume":"21","author":"Lecoultre","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"key20191128203548_b30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jnutbio.2009.05.006","article-title":"Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease","volume":"20","author":"Spruss","year":"2009","journal-title":"J Nutr Biochem"},{"key":"key20191128203548_b31","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/hep.21499","article-title":"Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats","volume":"45","author":"Roglans","year":"2007","journal-title":"Hepatology"},{"key":"key20191128203548_b32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2119\/2007-00119.Tilg","article-title":"Inflammatory mechanisms in the regulation of insulin resistance","volume":"14","author":"Tilg","year":"2008","journal-title":"Mol Med"},{"key":"key20191128203548_b33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1155\/2008\/810961","article-title":"Soft drink consumption linked with fatty liver in the absence of traditional risk factors","volume":"22","author":"Assy","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"key20191128203548_b34","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J Hepatol"},{"key":"key20191128203548_b35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2007.06.020","article-title":"Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study","volume":"47","author":"Zelber-Sagi","year":"2007","journal-title":"J Hepatol"},{"key":"key20191128203548_b36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1172\/JCI10583","article-title":"Cellular mechanisms of insulin resistance","volume":"106","author":"Shulman","year":"2000","journal-title":"J Clin Invest"},{"key":"key20191128203548_b37","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2337\/diabetes.51.4.1022","article-title":"Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity","volume":"51","author":"Sinha","year":"2002","journal-title":"Diabetes"},{"key":"key20191128203548_b38","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.2337\/diabetes.48.8.1600","article-title":"Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents","volume":"48","author":"Perseghin","year":"1999","journal-title":"Diabetes"},{"key":"key20191128203548_b39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s001250051123","article-title":"Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study","volume":"42","author":"Krssak","year":"1999","journal-title":"Diabetologia"},{"key":"key20191128203548_b40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI5001","article-title":"Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity","volume":"103","author":"Dresner","year":"1999","journal-title":"J Clin Invest"},{"key":"key20191128203548_b41","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1172\/JCI118742","article-title":"Mechanism of free fatty acid-induced insulin resistance in humans","volume":"97","author":"Roden","year":"1996","journal-title":"J Clin Invest"},{"key":"key20191128203548_b42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/diabetes.47.3.381","article-title":"13C\/31P NMR studies on the mechanism of insulin resistance in obesity","volume":"47","author":"Petersen","year":"1998","journal-title":"Diabetes"},{"key":"key20191128203548_b43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJM199907223410404","article-title":"Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes","volume":"341","author":"Cline","year":"1999","journal-title":"N Engl J Med"},{"key":"key20191128203548_b44","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJM199610313351804","article-title":"Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects","volume":"335","author":"Perseghin","year":"1996","journal-title":"N Engl J Med"},{"key":"key20191128203548_b45","doi-asserted-by":"crossref","first-page":"50230","DOI":"10.1074\/jbc.M200958200","article-title":"Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle","volume":"277","author":"Yu","year":"2002","journal-title":"J Biol Chem"},{"key":"key20191128203548_b46","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/diabetes.51.7.2005","article-title":"Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha","volume":"51","author":"Itani","year":"2002","journal-title":"Diabetes"},{"key":"key20191128203548_b47","doi-asserted-by":"crossref","first-page":"9597","DOI":"10.1073\/pnas.1409229111","article-title":"Role of diacylglycerol activation of PKC\u03b8 in lipid-induced muscle insulin resistance in humans","volume":"111","author":"Szendroedi","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20191128203548_b48","doi-asserted-by":"crossref","first-page":"45304","DOI":"10.1074\/jbc.C400186200","article-title":"Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101)","volume":"279","author":"Li","year":"2004","journal-title":"J Biol Chem"},{"key":"key20191128203548_b49","doi-asserted-by":"crossref","first-page":"12587","DOI":"10.1073\/pnas.0705408104","article-title":"The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome","volume":"104","author":"Petersen","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20191128203548_b50","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.2337\/db12-0206","article-title":"Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly","volume":"61","author":"Flannery","year":"2012","journal-title":"Diabetes"},{"key":"key20191128203548_b51","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"key":"key20191128203548_b52","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1074\/jbc.275.12.8456","article-title":"Mechanism of insulin resistance in A-ZIP\/F-1 fatless mice","volume":"275","author":"Kim","year":"2000","journal-title":"J Biol Chem"},{"key":"key20191128203548_b53","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1073\/pnas.121164498","article-title":"Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance","volume":"98","author":"Kim","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20191128203548_b54","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"key20191128203548_b55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1677\/joe.0.1620207","article-title":"Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats - effects of feeding","volume":"162","author":"Qu","year":"1999","journal-title":"J Endocrinol"},{"key":"key20191128203548_b56","doi-asserted-by":"crossref","first-page":"32345","DOI":"10.1074\/jbc.M313478200","article-title":"Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease","volume":"279","author":"Samuel","year":"2004","journal-title":"J Biol Chem"},{"key":"key20191128203548_b57","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI30400","article-title":"Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease","volume":"117","author":"Samuel","year":"2007","journal-title":"J Clin Invest"},{"key":"key20191128203548_b58","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00125-011-2073-0","article-title":"Time-dependent effects of Prkce deletion on glucose homeostasis and hepatic lipid metabolism on dietary lipid oversupply in mice","volume":"54","author":"Raddatz","year":"2011","journal-title":"Diabetologia"},{"key":"key20191128203548_b59","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1172\/JCI86013","article-title":"Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance","volume":"126","author":"Petersen","year":"2016","journal-title":"J Clin Invest"},{"key":"key20191128203548_b60","doi-asserted-by":"crossref","first-page":"16381","DOI":"10.1073\/pnas.1113359108","article-title":"Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease","volume":"108","author":"Kumashiro","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20191128203548_b61","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1053\/j.gastro.2012.03.003","article-title":"Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects","volume":"142","author":"Magkos","year":"2012","journal-title":"Gastroenterology"},{"key":"key20191128203548_b62","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen","year":"2016","journal-title":"J Hepatol"},{"key":"key20191128203548_b63","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.celrep.2017.05.035","article-title":"Hepatic diacylglycerol-associated protein kinase C\u025b translocation links hepatic steatosis to hepatic insulin resistance in humans","volume":"19","author":"Ter Horst","year":"2017","journal-title":"Cell Rep"},{"key":"key20191128203548_b64","doi-asserted-by":"crossref","first-page":"10455","DOI":"10.1074\/jbc.M117.786525","article-title":"Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice","volume":"292","author":"Irimia","year":"2017","journal-title":"J Biol Chem"},{"key":"key20191128203548_b65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature10986","article-title":"A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism","volume":"484","author":"Herman","year":"2012","journal-title":"Nature"},{"key":"key20191128203548_b66","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cell.2014.09.035","article-title":"Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects","volume":"159","author":"Yore","year":"2014","journal-title":"Cell"},{"key":"key20191128203548_b67","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1172\/JCI41636","article-title":"The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans","volume":"122","author":"Benhamed","year":"2012","journal-title":"J Clin Invest"},{"key":"key20191128203548_b68","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000282083","article-title":"The role of cytokines in non-alcoholic fatty liver disease","volume":"28","author":"Tilg","year":"2010","journal-title":"Dig Dis"},{"key":"key20191128203548_b69","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key20191128203548_b70","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/j.1440-1746.2009.06039.x","article-title":"Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis","volume":"24","author":"Asano","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"key20191128203548_b71","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1074\/jbc.M505311200","article-title":"Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists","volume":"281","author":"Nawrocki","year":"2006","journal-title":"J Biol Chem"},{"key":"key20191128203548_b72","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"key":"key20191128203548_b73","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"key20191128203548_b74","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1194\/jlr.M600471-JLR200","article-title":"NF-kappaB is important for TNF-alpha-induced lipolysis in human adipocytes","volume":"48","author":"Laurencikiene","year":"2007","journal-title":"J Lipid Res"},{"key":"key20191128203548_b75","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1194\/jlr.M008771","article-title":"Regulation of fat specific protein 27 by isoproterenol and TNF-\u03b1 to control lipolysis in murine adipocytes","volume":"52","author":"Ranjit","year":"2011","journal-title":"J Lipid Res"},{"key":"key20191128203548_b76","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cmet.2011.01.008","article-title":"Brain insulin controls adipose tissue lipolysis and lipogenesis","volume":"13","author":"Scherer","year":"2011","journal-title":"Cell Metab"},{"key":"key20191128203548_b77","doi-asserted-by":"crossref","first-page":"33061","DOI":"10.1074\/jbc.M111.307348","article-title":"Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis","volume":"287","author":"Scherer","year":"2012","journal-title":"J Biol Chem"},{"key":"key20191128203548_b78","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1210\/jc.2013-3169","article-title":"Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans","volume":"99","author":"Iwen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"key20191128203548_b79","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-94-007-2869-1_9","article-title":"Role of mitochondrial function in insulin resistance","volume":"942","author":"Brands","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"key20191128203548_b80","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"key":"key20191128203548_b81","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"key":"key20191128203548_b82","first-page":"422","article-title":"High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease","volume":"61","author":"Yeniova","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"key20191128203548_b83","doi-asserted-by":"crossref","first-page":"e000019","DOI":"10.1136\/bmjgast-2014-000019","article-title":"Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease","volume":"2","author":"Wood","year":"2015","journal-title":"BMJ Open Gastroenterol"},{"key":"key20191128203548_b84","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/ijo.2011.154","article-title":"Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content","volume":"36","author":"Peter","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"key20191128203548_b85","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1056\/NEJMoa0907295","article-title":"Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease","volume":"362","author":"Petersen","year":"2010","journal-title":"N Engl J Med"},{"key":"key20191128203548_b86","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1007\/s10620-016-4120-7","article-title":"APOC3 rs2070666 is associated with the hepatic steatosis independently of PNPLA3 rs738409 in Chinese Han patients with nonalcoholic fatty liver diseases","volume":"61","author":"Zhang","year":"2016","journal-title":"Dig Dis Sci"},{"key":"key20191128203548_b87","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.1323785111","article-title":"TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content","volume":"111","author":"Mahdessian","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20191128203548_b88","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2016.07.045","article-title":"The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans","volume":"65","author":"Luukkonen","year":"2016","journal-title":"J Hepatol"},{"key":"key20191128203548_b89","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"key20191128203548_b90","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12828","article-title":"Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico","volume":"506","author":"Williams","year":"2014","journal-title":"Nature"},{"key":"key20191128203548_b91","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cell.2017.06.011","article-title":"Type 2 diabetes variants disrupt function of SLC16A11 through two distinct mechanisms","volume":"170","author":"Rusu","year":"2017","journal-title":"Cell"},{"key":"key20191128203548_b92","doi-asserted-by":"crossref","first-page":"2862173","DOI":"10.1155\/2016\/2862173","article-title":"The pathogenesis of nonalcoholic fatty liver disease: Interplay between diet, gut microbiota, and genetic background","volume":"2016","author":"Yu","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"key20191128203548_b93","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.3390\/nu6125583","article-title":"The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease","volume":"6","author":"Ferolla","year":"2014","journal-title":"Nutrients"},{"key":"key20191128203548_b94","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis","volume":"48","author":"Wigg","year":"2001","journal-title":"Gut"},{"key":"key20191128203548_b95","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"key20191128203548_b96","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature18646","article-title":"Human gut microbes impact host serum metabolome and insulin sensitivity","volume":"535","author":"Pedersen","year":"2016","journal-title":"Nature"},{"key":"key20191128203548_b97","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/MEG.0000000000001232","article-title":"Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot","volume":"30","author":"Abdel-Razik","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20191128203548_b98","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.redox.2018.01.009","article-title":"Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches","volume":"15","author":"Borrelli","year":"2018","journal-title":"Redox Biol"},{"key":"key20191128203548_b99","first-page":"10","article-title":"Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis","volume":"107","author":"Ampuero","year":"2015","journal-title":"Rev Esp Enferm Dig"},{"key":"key20191128203548_b100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/hep4.1155","article-title":"Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta-analysis","volume":"2","author":"Zhou","year":"2018","journal-title":"Hepatol Commun"},{"key":"key20191128203548_b101","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.dld.2016.09.002","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis","volume":"48","author":"Jaruvongvanich","year":"2016","journal-title":"Dig Liver Dis"},{"key":"key20191128203548_b102","doi-asserted-by":"crossref","first-page":"E165","DOI":"10.1111\/hepr.12554","article-title":"Association of non-alcoholic fatty liver disease with impaired endothelial function by flow-mediated dilation: A meta-analysis","volume":"46","author":"Fan","year":"2016","journal-title":"Hepatol Res"},{"key":"key20191128203548_b103","first-page":"7673","article-title":"Association between nonalcoholic fatty liver disease and carotid atherosclerosis: a meta-analysis","volume":"8","author":"Cai","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key20191128203548_b104","doi-asserted-by":"crossref","first-page":"e2760","DOI":"10.1097\/MD.0000000000002760","article-title":"Nonalcoholic fatty liver disease is associated with higher 1-year all-cause rehospitalization rates in patients admitted for acute heart failure","volume":"95","author":"Valbusa","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key20191128203548_b105","doi-asserted-by":"crossref","first-page":"e001979","DOI":"10.1161\/CIRCIMAGING.114.001979","article-title":"Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease","volume":"8","author":"Gran\u00e9r","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"key20191128203548_b106","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/pace.12512","article-title":"Arrhythmogenic evidence for epicardial adipose tissue: heart rate variability and turbulence are influenced by epicardial fat thickness","volume":"38","author":"Balcio\u011flu","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"key20191128203548_b107","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.numecd.2014.01.005","article-title":"Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes","volume":"24","author":"Targher","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"key20191128203548_b108","doi-asserted-by":"crossref","first-page":"e001820","DOI":"10.1161\/JAHA.115.001820","article-title":"Nonalcoholic fatty liver disease is associated with QT prolongation in the general population","volume":"4","author":"Hung","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"key20191128203548_b109","doi-asserted-by":"crossref","first-page":"e0185459","DOI":"10.1371\/journal.pone.0185459","article-title":"Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus","volume":"12","author":"Mantovani","year":"2017","journal-title":"PLoS One"},{"key":"key20191128203548_b110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/CS20130036","article-title":"Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes","volume":"125","author":"Targher","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"key20191128203548_b111","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0161734615595015","article-title":"Doppler tissue evaluation of atrial conduction properties in patients with non-alcoholic fatty-liver disease","volume":"38","author":"Ozveren","year":"2016","journal-title":"Ultrason Imaging"},{"key":"key20191128203548_b112","doi-asserted-by":"crossref","first-page":"e57183","DOI":"10.1371\/journal.pone.0057183","article-title":"Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes","volume":"8","author":"Targher","year":"2013","journal-title":"PLoS One"},{"key":"key20191128203548_b113","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"key20191128203548_b114","doi-asserted-by":"crossref","first-page":"33386","DOI":"10.1038\/srep33386","article-title":"Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"key20191128203548_b115","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"key20191128203548_b116","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/liv.13973","article-title":"Cardiovascular risk factors in non-alcoholic fatty liver disease","volume":"39","author":"Hagstr\u00f6m","year":"2019","journal-title":"Liver Int"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.xiahepublishing.com\/2310-8819\/ArticleFullText.aspx?sid=2&id=10.14218%2fJCTH.2019.00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:17:41Z","timestamp":1783707461000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.xiahepublishing.com\/2310-8819\/ArticleFullText.aspx?sid=2&id=10.14218%2fJCTH.2019.00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":116,"journal-issue":{"issue":"X","published-online":{"date-parts":[[2019,11,29]]},"published-print":{"date-parts":[[2019,12,28]]}},"alternative-id":["10.14218\/JCTH.2019.00028"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2019.00028","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]}}}